EMEA-001584-PIP01-13-M06
Table of contents
Key facts
| Invented name |
Vemlidy
|
| Active substance |
Tenofovir alafenamide (as fumarate)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0269/2021
|
| PIP number |
EMEA-001584-PIP01-13-M06
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of chronic viral hepatitis B
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Gilead Sciences International Ltd.
Tel. +44 (0)1223 897 300 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|